Obregon, Mark Vincent T.

HRN: 29-29-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
CEFTRIAXONE 1G (VIAL)
07/12/2026
07/18/2026
IV
2g
OD
Bacterial Infection
Checking Initial Appropriateness 
07/21/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/21/2026
07/27/2026
IV
4.5g
Q8h
CAP-HR
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: